Persistent Pulmonary Hypertension of the Newborn

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Paediatric drugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00148581-200608030-00004PMID 16774297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitric oxide for respiratory failure in infants born at or near term.

  2017cited by this paper
• Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.

  2008cited by this paper
• Cor triatriatum masked by primary pulmonary hypertension

  2006cited by this paper
• Persistent pulmonary hypertension of newborn due to congenital capillary alveolar dysplasia

  2005cited by this paper
• Interaction between Inhaled Nitric Oxide and Intravenous Sildenafil in a Porcine Model of Meconium Aspiration Syndrome

  2004cited by this paper
• Long-term outcome following extracorporeal membrane oxygenation for congenital diaphragmatic hernia: the UK experience.

  2004cited by this paper
• Significance of pulmonary venous obstruction in total anomalous pulmonary venous return.

  2004cited by this paper
• Congenital Diaphragmatic Hernia Repair on Extracorporeal Life Support: A Decade of Lessons Learned

  2004cited by this paper
• Use of extracorporeal membrane oxygenation to rescue a newborn with early-onset group B streptococcal sepsis and cardiopulmonary failure.

  2004cited by this paper
• Nitric oxide in preterm infant with pulmonary hypoplasia

  2004cited by this paper
• Venovenous versus venoarterial extracorporeal membrane oxygenation in congenital diaphragmatic hernia.

  2003cited by this paper
• Cardiopulmonary outcome of neonatal extracorporeal membrane oxygenation at ages 10–15 years

  2003cited by this paper
• New methods advance treatment for respiratory distress syndrome.

  2003cited by this paper
• Extracorporeal membrane oxygenation for perinatal and pediatric patients.

  2003cited by this paper
• Inhaled Nitric Oxide in the Treatment of Moderate Persistent Pulmonary Hypertension of the Newborn: A Randomized Controlled, Multicenter Trial

  2003cited by this paper
• Innovative neonatal ventilation and meconium aspiration syndrome

  2003cited by this paper
• The development and use of extracorporeal membrane oxygenation in neonates.

  2003cited by this paper
• Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review.

  2003cited by this paper
• Extracorporeal life support - state of the art.

  2003cited by this paper
• Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review

  2003cited by this paper
• Outcome at 2 years of infants with congenital diaphragmatic hernia: a population-based study.

  2003cited by this paper
• Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/spontaneous respiration/elective repair.

  2002cited by this paper
• Sildenafil (Viagra) in childhood and neonatal pulmonary hypertension

  2002cited by this paper
• Permissive hypercapnia.

  2002cited by this paper
• A 16-year neonatal/pediatric extracorporeal membrane oxygenation transport experience.

  2002cited by this paper
• Extracorporeal membrane oxygenation for severe respiratory failure.

  2002cited by this paper
• Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.

  2002cited by this paper
• A comparison of clinical variables that predict adverse outcome in term infants with severe respiratory failure randomised to a policy of extracorporeal membrane oxygenation or to conventional neonatal intensive care

  2002cited by this paper
• Congenital diaphragmatic hernia.

  2002cited by this paper
• The impact of changing neonatal respiratory management on extracorporeal membrane oxygenation utilization.

  2002cited by this paper
• Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide.

  2002cited by this paper
• Hypoplastic left heart syndrome with intact atrial septum: Levoatriocardinal vein stent placement as a bridge to surgery

  2002cited by this paper
• Inhaled Nitric Oxide and Gentle Ventilation in the Treatment of Pulmonary Hypertension of the Newborn — a Single-Center, 5-Year Experience

  2002cited by this paper
• Type I nitric oxide synthase is decreased in the fetal pulmonary circulation of hypertensive lambs

  2002cited by this paper
• Pharmacologic therapy of persistent pulmonary hypertension of the newborn.

  2001cited by this paper
• Venoarterial versus venovenous extracorporeal membrane oxygenation in congenital diaphragmatic hernia: the Extracorporeal Life Support Organization Registry, 1990-1999.

  2001cited by this paper
• Hypocapnia and hypercapnia in respiratory management of newborn infants.

  2001cited by this paper
• Pulmonary morbidity in 100 survivors of congenital diaphragmatic hernia monitored in a multidisciplinary clinic.

  2001cited by this paper
• Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants.

  2001cited by this paper
• Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology.

  2001cited by this paper
• Inhaled nitric oxide in neonates with persistent pulmonary hypertension.

  2001cited by this paper
• Persistent pulmonary hypertension of the newborn: echocardiographic assessment.

  2001cited by this paper
• Comparison of high-frequency flow interruption ventilation and hyperventilation in persistent pulmonary hypertension of the newborn.

  2001cited by this paper
• Hypercalcemia associated with extracorporeal life support in neonates.

  2001cited by this paper
• Nitric oxide for respiratory failure in infants born at or near term.

  2001cited by this paper
• New trends in extracorporeal membrane oxygenation in newborn pulmonary diseases.

  2001cited by this paper
• In vitro performance characteristics of high-frequency oscillatory ventilators.

  2001cited by this paper
• [Treatment of persistent pulmonary hypertension of the newborn]

  2001cited by this paper
• Mandatory admission after isolated mild closed head injury in children: is it necessary?

  2001cited by this paper
• Rescue high frequency oscillatory ventilation vs conventional ventilation for infants with severe pulmonary dysfunction born at or near term.

  2001cited by this paper
• Nosocomial infections during extracorporeal membrane oxygenation

  2001cited by this paper
• Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn

  2001cited by this paper
• Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn.

  2001cited by this paper
• The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia.

  2001cited by this paper
• Secondary Infection Presenting as Recurrent Pulmonary Hypertension

  2000cited by this paper
• The current status of neonatal extracorporeal membrane oxygenation.

  2000cited by this paper
• Two years' follow-up of newborn infants after extracorporeal membrane oxygenation (ECMO).

  2000cited by this paper
• Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes

  2000cited by this paper
• Venovenous versus venoarterial extracorporeal life support for pediatric respiratory failure: Are there differences in survival and acute complications?

  2000cited by this paper
• Do we need new indications for ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric oxide?

  2000cited by this paper
• Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia.

  2000cited by this paper
• Sildenafil Is a Pulmonary Vasodilator in Awake Lambs with Acute Pulmonary Hypertension

  2000cited by this paper
• Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization.

  2000cited by this paper
• Neurodevelopmental outcome at 3.5 years of age in children treated with extracorporeal life support: relationship to primary diagnosis.

  2000cited by this paper
• Respiratory function in survivors of the United Kingdom Extracorporeal Membrane Oxygenation Trial.

  2000cited by this paper
• Neurodevelopmental Outcome in ECMO Vs Near-Miss ECMO Patients at 5 Years of Age

  2000cited by this paper
• ECMO IN THE NEWBORN

  2000cited by this paper
• Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn

  2000cited by this paper
• Comparison of venoarterial versus venovenous access in the cerebral circulation of newborns undergoing extracorporeal membrane oxygenation

  2000cited by this paper
• Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.

  1999cited by this paper
• Randomized, Controlled Trial of Low-dose Inhaled Nitric Oxide in the Treatment of Term and Near-term Infants With Respiratory Failure and Pulmonary Hypertension

  1999cited by this paper
• A Review of 100 Patients Transported on Extracorporeal Life Support

  1999cited by this paper
• Endothelin-1 levels in infants with pulmonary hypertension receiving extracorporeal membrane oxygenation

  1999cited by this paper
• Survivors of neonatal extracorporeal membrane oxygenation at school age: unusual findings on intelligence testing

  1999cited by this paper
• Cerebral blood flow during treatment for pulmonary hypertension

  1999cited by this paper
• Comparison of venoarterial versus venovenous access in the cerebral circulation of newborns undergoing extracorporeal membrane oxygenation

  1999cited by this paper
• Pulmonary barotrauma in congenital diaphragmatic hernia: a clinicopathological correlation.

  1999cited by this paper
• High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group.

  1998cited by this paper
• Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity.

  1998cited by this paper
• Controversies in the use of inhaled nitric oxide therapy in the newborn.

  1998cited by this paper
• Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity.

  1998cited by this paper
• A retrospective study of infants with severe persistent pulmonary hypertension (PPHN) managed without extracorporeal membrane oxygenation (ECMO).

  1998cited by this paper
• Percutaneous access for venovenous extracorporeal life support in neonates.

  1998cited by this paper
• High-Frequency Oscillatory Ventilation Augments the Response to Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn

  1998cited by this paper
• Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study

  1998cited by this paper
• Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group.

  1998cited by this paper
• Improved Oxygenation following Adenosine Infusion in Persistent Pulmonary Hypertension of the Newborn

  1998cited by this paper
• Pulmonary and Systemic Effects of the Phosphodiesterase Inhibitor Dipyridamole in Newborn Lambs with Persistent Pulmonary Hypertension

  1998cited by this paper
• Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

  1997cited by this paper
• Determination of gas‐trapping during high frequency oscillatory ventilation

  1997cited by this paper
• Extracorporeal membrane oxygenation causing asymmetric vasculopathy in neonatal infants.

  1997cited by this paper
• Maternal tobacco smoke exposure and persistent pulmonary hypertension of the newborn.

  1997cited by this paper
• Congenital diaphragmatic hernia--a tale of two cities: the Boston experience.

  1997cited by this paper
• Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn

  1997cited by this paper
• Prostacyclin Treatment for Persistent Pulmonary Hypertension of the Newborn

  1997cited by this paper
• Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn.

  1997cited by this paper
• Immunohistochemical distribution of surfactant apoprotein-A in congenital diaphragmatic hernia.

  1997cited by this paper
• Controlled prospective randomized comparison of high-frequency jet ventilation and conventional ventilation in neonates with respiratory failure and persistent pulmonary hypertension.

  1997cited by this paper
• Effect of nitric oxide in meconium aspiration syndrome after treatment with surfactant.

  1997cited by this paper
• Models of persistent pulmonary hypertension of the newborn (PPHN) and the role of cyclic guanosine monophosphate (GMP) in pulmonary vasorelaxation.

  1997cited by this paper

• Nebulized nitroglycerin as an adjuvant drug in management of persistent pulmonary hypertension of newborns: a randomized controlled trial

  2025cites this paper
• Defining the Typical Course of Persistent Pulmonary Hypertension of the Newborn (PPHN): when to think beyond reversible causes.

  2024cites this paper
• Serum pentraxin 3 levels in term neonates with persistent pulmonary hypertension

  2024cites this paper
• Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders

  2023influential citation
• Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta‐analysis

  2021cites this paper
• Evidence-Based Guidelines for Acute Stabilization and Management of Neonates with Persistent Pulmonary Hypertension of the Newborn

  2021cites this paper
• Oral drugs used to treat persistent pulmonary hypertension of the newborn

  2020cites this paper
• Pulmonary hypertension in newborn infants: pathophysiology, clinical assessment and management

  2020cites this paper
• Evidence Based Approach to the Management of Persistent Pulmonary Hypertension of the Newborn (PPHN)

  2020cites this paper
• Pentraxin 3: A Potential Novel Predictor for Neonatal Pulmonary Hypertension

  2019cites this paper
• Lung Ultrasound to Assess the Etiology of Persistent Pulmonary Hypertension of the Newborn (LUPPHYN Study): A Pilot Study

  2019cites this paper
• Echocardiographic Evaluation of Transitional Circulation for the Neonatologists

  2018cites this paper
• Maternal use of selective serotonin‐reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn

  2016cites this paper
• A role for actin polymerization in persistent pulmonary hypertension of the newborn.

  2015cites this paper
• The use of equine surfactant and positive pressure ventilation to treat a premature alpaca cria with severe hypoventilation and hypercapnia.

  2015cites this paper
• Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn

  2014cites this paper
• Thromboxane-induced actin polymerization in hypoxic neonatal pulmonary arterial myocytes involves Cdc42 signaling.

  2014cites this paper
• Evaluation of persistent pulmonary hypertension of the newborn (PPHN) in Upper Egypt

  2013cites this paper
• Hydralazine in infants with persistent hypoxemic respiratory failure.

  2013cites this paper
• Pathophysiology, Management, and Outcome of Persistent Pulmonary Hypertension of the Newborn: A Clinical Review

  2013cites this paper
• Risk Factors and Outcomes of Persistent Pulmonary Hypertension of the Newborn in Neonatal Intensive Care Unit of Al-Minya University Hospital in Egypt

  2013cites this paper
• Persistent pulmonary hypertension of the newborn

  2012cites this paper
• A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn

  2012cites this paper
• Molecular Mechanisms Regulating the Vascular Prostacyclin Pathways and Their Adaptation during Pregnancy and in the Newborn

  2012cites this paper
• Classification of pulmonary hypertension.

  2012cites this paper
• Persistent pulmonary hypertension results in reduced tetralinoleoyl-cardiolipin and mitochondrial complex II + III during the development of right ventricular hypertrophy in the neonatal pig heart.

  2011cites this paper
• Hydralazine for pulmonary hypertension in low birth weight infants with chronic lung disease

  2011cites this paper
• Pentoxifylline in Preterm Neonates

  2010cites this paper
• Congenital segmental dilatation of the duodenum: Report of a case

  2010cites this paper
• Expression of HIF-1 alpha, VEGF and EPO in peripheral blood from patients with two cardiac abnormalities associated with hypoxia.

  2010cites this paper
• A 20-year experience on neonatal extracorporeal membrane oxygenation in a referral center

  2010cites this paper
• Use of the Myocardial Performance Index to Assess Right Ventricular Function in Infants with Pulmonary Hypertension

  2009cites this paper
• Neonates with congenital cardiac defects and pulmonary hypertension

  2009cites this paper
• Anesthesia for Thoracic Surgery

  2009cites this paper
• Transport of the Neonatal Patient With Persistent Pulmonary Hypertension

  2009cites this paper
• Persistent pulmonary hypertension of the newborn)

  2009cites this paper
• Prenatal prediction of neonatal morbidity in survivors with congenital diaphragmatic hernia: a multicenter study

  2009cites this paper
• Chapter 13 – Evidence-based Evaluation of the Management of Neonatal Shock

  2008cites this paper
• Nitric oxide and cardiac function.

  2007cites this paper
• M2 – Abklärung einer Zyanose (S2)

  2007cites this paper